Back to all studies
RecruitingNCT07266545

RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Depression in bipolarity (EDIT-ANDRE)

This recruiting study focuses on bipolarity and currently lists sites or participation links in United States.

BipolarityOtherFrom 18 Years to 65 Years
In plain English

Key information made simple

This study exists to explore whether blood tests and biological markers could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory. The findings could guide better understanding and future care, and taking part helps build that evidence for others.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including Mayo Clinic in Rochester in Rochester. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually being able to understand the study and consent and matching the main diagnosis. This is a later-stage study, which usually means the approach is being followed in broader real-world use.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT07266545. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in United States.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com